Guangxi Liuyao Group603368.SHValuation Analysis

As of Oct 19, 2026, Guangxi Liuyao Group (603368.SH) trades at a P/E of 9.49x, P/B of 0.78x, P/S of 0.29x, and a dividend yield of 4.28%.
Longitudinal percentile comparison: P/E sits at the 26th percentile over the trailing 10Y window (vs. 71st percentile over 3Y); P/B sits at the 3rd percentile over the trailing 10Y window (vs. 10th percentile over 3Y); P/S sits at the 5th percentile over the trailing 10Y window (vs. 13th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 1st percentile within its industry and the 3rd percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 7.50%, ranking at the 98th percentile over the trailing 20Y window.
Notably, P/E and P/B aren't telling quite the same story, 23.1 points apart — worth checking the full percentile matrix on this page for the complete picture. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Of the 7.50% total shareholder yield, 4.28% is paid out as dividends and roughly 3.22% is implied to come from buybacks — both channels are meaningfully in play. Guangxi Liuyao Group operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.